Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.
Kester, Maartje I
Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype. [electronic resource] - Neurobiology of aging Aug 2011 - 1372-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1558-1497
10.1016/j.neurobiolaging.2009.08.006 doi
Aged
Alzheimer Disease--cerebrospinal fluid
Amyloid beta-Peptides--cerebrospinal fluid
Apolipoprotein E4--genetics
Cognitive Dysfunction--cerebrospinal fluid
Disease Progression
Female
Genetic Carrier Screening
Genotype
Homozygote
Humans
Male
Middle Aged
Peptide Fragments--cerebrospinal fluid
Predictive Value of Tests
Severity of Illness Index
Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype. [electronic resource] - Neurobiology of aging Aug 2011 - 1372-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1558-1497
10.1016/j.neurobiolaging.2009.08.006 doi
Aged
Alzheimer Disease--cerebrospinal fluid
Amyloid beta-Peptides--cerebrospinal fluid
Apolipoprotein E4--genetics
Cognitive Dysfunction--cerebrospinal fluid
Disease Progression
Female
Genetic Carrier Screening
Genotype
Homozygote
Humans
Male
Middle Aged
Peptide Fragments--cerebrospinal fluid
Predictive Value of Tests
Severity of Illness Index